Marvel Biosciences' Lead Drug Candidate MB-204 Demonstrates a 400% Increase in the Survival Rate of Animals Treated with a High Dose of the Cancer Treatment Cis-Platinum

Stock Information for Marvel Biosciences Corp.

Loading

Please wait while we load your information from QuoteMedia.